Head OfficeNovartis International AGCH-4002 BaselSwitzerland
+41 61 324 11 11+41 61 324 80 01Monday - Friday,8:30 - 17:00, GMT+1(Central European Time)
More information
Novartis International AGInvestor RelationsP.O. BoxCH-4002 BaselSwitzerland
+41 61 324 79 44investor.relations@novartis.com
Global Media RelationsEric AlthoffBasel, Switzerland
+41 61 324 7999eric.althoff@novartis.com
01-Feb-2012FDA approves Novartis drug Glivec® label recommending extending treatment to three years for certain GIST patients after surgery
30-Jan-2012Novartis extends commitment to help achieve final elimination of leprosy
25-Jan-2012Novartis delivers strong underlying financial performance in 2011, expects 2012 sales to be in line with 2011
View all press releases
Sign up for email alerts
English newsfeed
German newsfeed
French newsfeed
Follow Novartis on Twitter
Alcon information center
Pharmaceutical products
Clinical pipeline
Management bios
December 13 oncology call presentation (1.9 MB)
Form 20-F 2011 (2.0 MB)
Corporate organizational structure (41 KB)
Stock performance
Annual report 2011 >